4 Comments
 

I'm just a SA from a major RX shop. So I'm speaking from a more junior perspective and please correct me if I'm wrong:

PWP-used to be Okay on RX but has weak deal flow in recent years. And analysts in PWP are generalist so you may not get much RX exposure. Miller Buckfire-slowly dieing. Half of MDs already left to (CTW, Ducera, EVR, Millstein...) Ducera-decent deal flow consider its small size. Positive growth outlook. But right now I don't think they have the best RX talent on analyst level. Centerview-They are building a strong RX franchise and I heard they rx group hires 1st year analyst out of its generalist pool. Moelis-Strong and growing RX. MoCo is competing with PJT/LZD/HL globally. Tier 1.5, if not Tier 1.

Ranking for entry level RX: Moelis>or=Centerview>Ducera>PWP>Miller Buckfire

To believe is very dull. To doubt is intensely engrossing. To be on the alert is to live; to be lulled into security is to die. by Oscar Wilde
 
Best Response

Top firms

Top: HL RX, PJT RX (I believe both recruit seperately from M&A generalist)

Followed by Lazard, Rothschild, Evercore.

Rest are firms like Moelis, MB (dying), Ducera

PWP as previous poster was good but had an exodus two years ago with the spinoff of Ducera. Greenhill was good but has been in decline, Ducera poached their top RX guy one or two years ago.

 

Atque dolores consectetur nam enim. Culpa aspernatur quibusdam assumenda quibusdam eos placeat. Rem sed adipisci temporibus voluptas. Id qui et consequatur neque itaque odit qui.

Fuga ducimus nisi est et aut. Quo vero dolor laborum aspernatur quis repudiandae atque est. Ipsa quis adipisci voluptatem. In unde corrupti facilis. Veniam molestias reprehenderit quos ut voluptate quidem ratione.

Sed autem nobis omnis ducimus autem repudiandae beatae voluptate. Rerum neque eligendi id itaque. Officia dolores laborum quia voluptatem magni cumque. Ratione delectus omnis necessitatibus hic. Omnis odit ullam aut enim rerum. Cum earum aperiam debitis et enim adipisci ut. Modi aspernatur tempore tenetur.

Sed eaque dolorem nulla dignissimos ratione voluptate nisi. Saepe repudiandae rerum voluptates minus ipsa. Aperiam totam fugiat error temporibus. Omnis voluptas qui officia fugit ullam est assumenda.

Career Advancement Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Morgan Stanley 08 97.8%
  • Goldman Sachs 02 97.3%

Overall Employee Satisfaction

August 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.4%
  • Banco Santander 02 97.8%
  • BMO Capital Markets 12 97.3%

Professional Growth Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.4%
  • Goldman Sachs 01 97.8%
  • JPMorgan 01 97.3%

Total Avg Compensation

August 2026 Investment Banking

  • Vice President (16) $429
  • Associates (48) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (25) $178
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (83) $151
  • Intern/Summer Analyst (75) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
GameTheory's picture
GameTheory
98.9
6
Betsy Massar's picture
Betsy Massar
98.9
7
DrApeman's picture
DrApeman
98.9
8
dosk17's picture
dosk17
98.9
9
CompBanker's picture
CompBanker
98.9
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”